Cytosorbents Cor (CTSO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2012 | 12-2011 | 09-2011 | 06-2011 | 03-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,427 | -5,480 | -4,285 | -2,556 | -1,215 |
| Depreciation Amortization | 355 | 980 | 853 | 334 | 94 |
| Accounts receivable | -4 | -36 | N/A | N/A | N/A |
| Other Working Capital | -1 | -190 | 204 | 423 | 357 |
| Other Operating Activity | 4 | 906 | 508 | 178 | 176 |
| Operating Cash Flow | $-1,072 | $-3,820 | $-2,720 | $-1,621 | $-588 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -30 | -34 | -17 | N/A |
| Purchase Sale Intangibles | -11 | -18 | -18 | -11 | N/A |
| Other Investing Activity | -11 | -20 | -18 | -11 | 0 |
| Investing Cash Flow | $-11 | $-50 | $-52 | $-28 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 700 | 1,250 | 1,250 | 1,250 | 1,250 |
| Common Stock Issued | N/A | 5 | 5 | 3 | N/A |
| Other Financing Activity | 1,000 | 2,755 | 2,757 | 2,757 | 719 |
| Financing Cash Flow | $1,700 | $4,010 | $4,012 | $4,010 | $1,969 |
| Beginning Cash Position | 1,187 | 1,050 | 1,056 | 1,056 | 1,056 |
| End Cash Position | 1,803 | 1,180 | 2,296 | 3,417 | 2,437 |
| Net Cash Flow | $616 | $130 | $1,241 | $2,361 | $1,381 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,072 | -3,820 | -2,720 | -1,621 | -588 |
| Capital Expenditure | N/A | -35 | -34 | -17 | N/A |
| Free Cash Flow | -1,072 | -3,855 | -2,754 | -1,638 | -588 |